FTCM
RYZB

First Trust Capital Management’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

First Trust Capital Management’s Portfolio RYZB Stock Details RYZB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-140,882
Closed -$8.76M – 153
2023
Q4 		$8.76M Buy
+140,882
New +$3.5M 0.67% 45

First Trust Capital Management's RYZB Position: Q1 2024 in Review

First Trust Capital Management sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 140,882 shares — an estimated $8.76M sold.

First Trust Capital Management first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $8.76M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

  • First Trust Capital Management reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • First Trust Capital Management sold 140,882 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $8.76M.
  • First Trust Capital Management first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • First Trust Capital Management's RayzeBio, Inc. Common Stock position peaked at $8.76M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on First Trust Capital Management's 13F filing for Q1 2024, filed 15 May 2024.